Sessa Capital IM, L.P.

Position in SABS — SAB Biotherapeutics, Inc.

CIK 1595849 NEW YORK, NY

Position in SABS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,573,982

+$153,892 QoQ

Shares Held

2,198,457

0.0% QoQ

Ownership

2.42%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#12

of 86 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Sessa Capital IM, L.P. holds $154,182,758 across 4 Biotechnology names. SABS ranks #4 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FTRE	Fortrea Holdings Inc.	4,593,550	$79,927,770
2	LXRX	Lexicon Pharmaceuticals, Inc.	18,960,836	$45,506,006
3	RNA	Atrium Therapeutics, Inc.	1,500,000	$20,175,000
4	SABS	SAB Biotherapeutics, Inc. This page	2,198,457	$8,573,982

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,573,982	2,198,457	0.0%	Shares	Sole	2026-08-14
2026-03-31	$8,420,090	2,198,457	0.0%	Shares	Sole	2026-05-15
2025-12-31	$8,222,229	2,198,457	0.0%	Shares	Sole	2026-02-17
2025-09-30	$4,418,898	2,198,457	+379.5%	Shares	Sole	2025-11-14
2025-06-30	$804,592	458,457	0.0%	Shares	Sole	2025-08-13
2025-03-31	$623,501	458,457	0.0%	Shares	Sole	2025-05-15
2024-12-31	$1,739,385	458,457	0.0%	Shares	Sole	2025-02-14
2024-09-30	$1,237,833	458,457	0.0%	Shares	Sole	2024-11-12
2024-06-30	$1,421,216	458,457	0.0%	Shares	Sole	2024-08-14
2024-03-31	$2,081,394	458,457	-90.0%	Shares	Sole	2024-05-15
2023-12-31	$3,154,184	4,584,571	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.